• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

July 2006: Additions and Deletions to the Drug Product List

25th Edition: Cumulative Supplement Number 7

[Prescription - OTC]

NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.5 CUMULATIVE SUPPLEMENT LEGEND.



ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
   ACETAMINOPHEN; CODEINE PHOSPHATE
          SOLUTION; ORAL
            ACETAMINOPHEN AND CODEINE PHOSPHATE
>A>   AA  +   ACTAVIS MID                120MG/5ML;12MG/5ML                      N85861 001                  Jul  CAHN
>D>   AA  +   ALPHARMA US                120MG/5ML;12MG/5ML                      N85861 001                  Jul  CAHN
          SUSPENSION; ORAL
            CAPITAL AND CODEINE
>A>   AA      ACTAVIS MID                120MG/5ML;12MG/5ML                      N85883 001                  Jul  CAHN
>D>   AA      ALPHARMA US                120MG/5ML;12MG/5ML                      N85883 001                  Jul  CAHN
          TABLET; ORAL
>D>         ACETAMINOPHEN W/ CODEINE NO. 3
>D>   AA      ROXANE                     300MG;30MG                              N84656 001                  Jul  DISC
>A>         @                            300MG;30MG                              N84656 001                  Jul  DISC
       ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE
          TABLET; ORAL
            PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
>A>           CORNERSTONE                325MG;100MG                             N76743 001  May 07, 2004    Jul  CAHN
>A>   AB                                 500MG;100MG                             N76750 001  Jun 28, 2004    Jul  CAHN
>D>           VINTAGE PHARMS             325MG;100MG                             N76743 001  May 07, 2004    Jul  CAHN
>D>   AB                                 500MG;100MG                             N76750 001  Jun 28, 2004    Jul  CAHN
       ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
          TABLET; ORAL
            ACETAMINOPHEN AND TRAMADOL HYDROCHLORIDE
>A>   AB      BARR                       325MG;37.5MG                            N76914 001  Jul 26, 2006    Jul  NEWA
       ACETIC ACID, GLACIAL
          SOLUTION/DROPS; OTIC
            ACETASOL
>A>   AT      ACTAVIS MID                2%                                      N87146 001                  Jul  CAHN
>D>   AT      ALPHARMA US                2%                                      N87146 001                  Jul  CAHN
       ACETIC ACID, GLACIAL; HYDROCORTISONE
          SOLUTION/DROPS; OTIC
            ACETASOL HC
>A>   AT      ACTAVIS MID                2%;1%                                   N87143 001  Jan 13, 1982    Jul  CAHN
>D>   AT      ALPHARMA US                2%;1%                                   N87143 001  Jan 13, 1982    Jul  CAHN
       ACYCLOVIR
          SUSPENSION; ORAL
            ACYCLOVIR
>A>   AB      ACTAVIS MID                200MG/5ML                               N74738 001  Apr 28, 1997    Jul  CAHN
>D>   AB      ALPHARMA US                200MG/5ML                               N74738 001  Apr 28, 1997    Jul  CAHN
       ALBUTEROL SULFATE
          SOLUTION; INHALATION
            ALBUTEROL SULFATE
>A>   AN      ACTAVIS MID                EQ 0.083% BASE                          N73533 001  Sep 26, 1995    Jul  CAHN
>D>   AN      ALPHARMA US                EQ 0.083% BASE                          N73533 001  Sep 26, 1995    Jul  CAHN
          SYRUP; ORAL
            ALBUTEROL SULFATE
>A>   AA      ACTAVIS MID                EQ 2MG BASE/5ML                         N75262 001  Mar 30, 1999    Jul  CAHN
>A>   AA                                 EQ 2MG BASE/5ML                         N74454 001  Sep 25, 1995    Jul  CAHN
>D>   AA      ALPHARMA US                EQ 2MG BASE/5ML                         N74454 001  Sep 25, 1995    Jul  CAHN
>D>   AA      UDL                        EQ 2MG BASE/5ML                         N75262 001  Mar 30, 1999    Jul  CAHN
       ALPRAZOLAM
          TABLET, EXTENDED RELEASE; ORAL
            ALPRAZOLAM
>A>   AB      BARR                       0.5MG                                   N77725 001  Jul 31, 2006    Jul  NEWA
>A>   AB                                 1MG                                     N77725 002  Jul 31, 2006    Jul  NEWA
>A>   AB                                 3MG                                     N77725 003  Jul 31, 2006    Jul  NEWA
       AMANTADINE HYDROCHLORIDE
          SYRUP; ORAL
            AMANTADINE HYDROCHLORIDE
>A>   AA  +   ACTAVIS MID                50MG/5ML                                N72655 001  Oct 30, 1990    Jul  CAHN
>D>   AA  +   ALPHARMA US                50MG/5ML                                N72655 001  Oct 30, 1990    Jul  CAHN
       AMINOPHYLLINE
          SOLUTION; ORAL
            AMINOPHYLLINE DYE FREE
>A>   AA  +   ACTAVIS MID                105MG/5ML                               N87727 001  Apr 16, 1982    Jul  CAHN
>D>   AA  +   ALPHARMA US                105MG/5ML                               N87727 001  Apr 16, 1982    Jul  CAHN
       AMPICILLIN SODIUM; SULBACTAM SODIUM
          INJECTABLE; INJECTION
            AMPICILLIN AND SULBACTAM
>A>   AP      SANDOZ                     EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL     N65310 001  Jul 25, 2006    Jul  NEWA
>A>   AP                                 EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL     N65241 001  Jul 25, 2006    Jul  NEWA
>A>   AP                                 EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL       N65310 002  Jul 25, 2006    Jul  NEWA
>A>   AP                                 EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL       N65241 002  Jul 25, 2006    Jul  NEWA
>A>   AP                                 EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL      N65240 001  Jul 25, 2006    Jul  NEWA
       ARIPIPRAZOLE
          TABLET; ORAL
            ABILIFY
>D>         @ OTSUKA                     2MG                                     N21436 006  Nov 15, 2002    Jul  CMFD
>A>                                      2MG                                     N21436 006  Nov 15, 2002    Jul  CMFD
       BETAMETHASONE DIPROPIONATE
          LOTION; TOPICAL
            BETAMETHASONE DIPROPIONATE
>A>   AB      ACTAVIS MID                EQ 0.05% BASE                           N70281 001  Jul 31, 1985    Jul  CAHN
>D>   AB      ALPHARMA US                EQ 0.05% BASE                           N70281 001  Jul 31, 1985    Jul  CAHN



        BETAMETHASONE VALERATE
          LOTION; TOPICAL
            BETAMETHASONE VALERATE
>A>   AB      ACTAVIS MID                EQ 0.1% BASE                            N70052 001  Jul 31, 1985    Jul  CAHN
>D>   AB      ALPHARMA US                EQ 0.1% BASE                            N70052 001  Jul 31, 1985    Jul  CAHN



        BUDESONIDE
          POWDER, METERED; INHALATION
>A>         BUDESONIDE
>A>           ASTRAZENECA                0.08MG/INH                              N21949 001  Jul 12, 2006    Jul  NEWA
>A>       +                              0.16MG/INH                              N21949 002  Jul 12, 2006    Jul  NEWA



>A>     BUDESONIDE; FORMOTEROL FUMARATE
>A>       SPRAY, METERED; INHALATION
>A>         SYMBICORT
>A>           ASTRAZENECA                0.08MG/INH;EQ 0.045MG BASE              N21929 001  Jul 21, 2006    Jul  NEWA
>A>       +                              0.016MG/INH;EQ 0.045MG BASE             N21929 002  Jul 21, 2006    Jul  NEWA



        CARBAMAZEPINE
          TABLET, CHEWABLE; ORAL
            CARBAMAZEPINE
>A>   AB      JUBILANT PHARMS            100MG                                   N71940 001  Feb 01, 1988    Jul  CAHN
>D>   AB      WARNER CHILCOTT            100MG                                   N71940 001  Feb 01, 1988    Jul  CAHN



        CEFADROXIL/CEFADROXIL HEMIHYDRATE
          FOR SUSPENSION; ORAL
            CEFADROXIL
>D>           RANBAXY                    EQ 125MG BASE/5ML                       N65115 001  Mar 26, 2003    Jul  CRLD
>A>       +                              EQ 125MG BASE/5ML                       N65115 001  Mar 26, 2003    Jul  CRLD



        CEFDINIR
          FOR SUSPENSION; ORAL
            CEFDINIR
>A>   AB      LUPIN                      125MG/5ML                               N65259 001  May 31, 2006    Jul  CAHN
>D>   AB      LUPIN (USA)                125MG/5ML                               N65259 001  May 31, 2006    Jul  CAHN



        CHLORHEXIDINE GLUCONATE
          SOLUTION; DENTAL
            CHLORHEXIDINE GLUCONATE
>A>   AT      ACTAVIS MID                0.12%                                   N74291 001  Dec 28, 1995    Jul  CAHN
>D>   AT      ALPHARMA US                0.12%                                   N74291 001  Dec 28, 1995    Jul  CAHN



        CHLOROPROCAINE HYDROCHLORIDE
          INJECTABLE; INJECTION
            NESACAINE
>A>       +   ABRAXIS BIOSCIENCE         1%                                      N09435 001                  Jul  CAHN
>A>   AP                                 2%                                      N09435 002                  Jul  CAHN
>D>       +   ASTRAZENECA                1%                                      N09435 001                  Jul  CAHN
>D>   AP                                 2%                                      N09435 002                  Jul  CAHN
            NESACAINE-MPF
>A>         @ ABRAXIS BIOSCIENCE         2%                                      N09435 003                  Jul  CAHN
>A>   AP  +                              2%                                      N09435 006  May 02, 1996    Jul  CAHN
>A>         @                            3%                                      N09435 004                  Jul  CAHN
>A>   AP  +                              3%                                      N09435 007  May 02, 1996    Jul  CAHN
>D>         @ ASTRAZENECA                2%                                      N09435 003                  Jul  CAHN
>D>   AP  +                              2%                                      N09435 006  May 02, 1996    Jul  CAHN
>D>         @                            3%                                      N09435 004                  Jul  CAHN
>D>   AP  +                              3%                                      N09435 007  May 02, 1996    Jul  CAHN



        CHLORPROMAZINE HYDROCHLORIDE
          CONCENTRATE; ORAL
            CHLORPROMAZINE HYDROCHLORIDE
>A>   AA      ACTAVIS MID                100MG/ML                                N86863 001                  Jul  CAHN
>D>   AA      ALPHARMA US                100MG/ML                                N86863 001                  Jul  CAHN



        CIMETIDINE HYDROCHLORIDE
          SOLUTION; ORAL
            CIMETIDINE HYDROCHLORIDE
>A>   AA  +   ACTAVIS MID                EQ 300MG BASE/5ML                       N74176 001  Jun 01, 1994    Jul  CAHN
>D>   AA  +   ALPHARMA US                EQ 300MG BASE/5ML                       N74176 001  Jun 01, 1994    Jul  CAHN



        CLEMASTINE FUMARATE
          SYRUP; ORAL
            CLEMASTINE FUMARATE
>A>   AA      ACTAVIS MID                EQ 0.5MG BASE/5ML                       N74075 001  Oct 31, 1993    Jul  CAHN
>D>   AA      ALPHARMA US                EQ 0.5MG BASE/5ML                       N74075 001  Oct 31, 1993    Jul  CAHN



        CLINDAMYCIN PHOSPHATE
          SOLUTION; TOPICAL
            CLINDAMYCIN PHOSPHATE
>A>   AT      ACTAVIS MID                EQ 1% BASE                              N62811 001  Sep 01, 1988    Jul  CAHN
>D>   AT      ALPHARMA US                EQ 1% BASE                              N62811 001  Sep 01, 1988    Jul  CAHN



        CLOBETASOL PROPIONATE
          SOLUTION; TOPICAL
            CLOBETASOL PROPIONATE
>A>   AT      ACTAVIS MID                0.05%                                   N74331 001  Dec 15, 1995    Jul  CAHN
>D>   AT      ALPHARMA US                0.05%                                   N74331 001  Dec 15, 1995    Jul  CAHN



        CLOZAPINE
          TABLET, ORALLY DISINTEGRATING; ORAL
            FAZACLO ODT
>D>           ALAMO PHARMS               25MG                                    N21590 001  Feb 10, 2004    Jul  CAHN
>D>                                      50MG                                    N21590 003  Jun 03, 2005    Jul  CAHN
>D>       +                              100MG                                   N21590 002  Feb 10, 2004    Jul  CAHN
>A>           AVANIR PHARMS              25MG                                    N21590 001  Feb 10, 2004    Jul  CAHN
>A>                                      50MG                                    N21590 003  Jun 03, 2005    Jul  CAHN
>A>       +                              100MG                                   N21590 002  Feb 10, 2004    Jul  CAHN



        CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
          SYRUP; ORAL
            PROMETH VC W/ CODEINE
>A>       +   ACTAVIS MID                10MG/5ML;5MG/5ML;6.25MG/5ML             N88764 001  Oct 31, 1984    Jul  CAHN
>D>       +   ALPHARMA US                10MG/5ML;5MG/5ML;6.25MG/5ML             N88764 001  Oct 31, 1984    Jul  CAHN



        CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
          SYRUP; ORAL
            PROMETH W/ CODEINE
>A>   AA  +   ACTAVIS MID                10MG/5ML;6.25MG/5ML                     N88763 001  Oct 31, 1984    Jul  CAHN
>D>   AA  +   ALPHARMA US                10MG/5ML;6.25MG/5ML                     N88763 001  Oct 31, 1984    Jul  CAHN



        CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
          SYRUP; ORAL
            TRIACIN-C
>A>   AA      ACTAVIS MID                10MG/5ML;30MG/5ML;1.25MG/5ML            N88704 001  Mar 22, 1985    Jul  CAHN
>D>   AA      ALPHARMA US                10MG/5ML;30MG/5ML;1.25MG/5ML            N88704 001  Mar 22, 1985    Jul  CAHN



        CROMOLYN SODIUM
          SOLUTION; INHALATION
            CROMOLYN SODIUM
>A>   AN      ACTAVIS MID                10MG/ML                                 N75067 001  Jul 19, 1999    Jul  CAHN
>D>   AN      ALPHARMA US                10MG/ML                                 N75067 001  Jul 19, 1999    Jul  CAHN



        CYPROHEPTADINE HYDROCHLORIDE
          SYRUP; ORAL
            CYPROHEPTADINE HYDROCHLORIDE
>A>   AA  +   ACTAVIS MID                2MG/5ML                                 N86833 001                  Jul  CAHN
>D>   AA  +   ALPHARMA US                2MG/5ML                                 N86833 001                  Jul  CAHN



        DEXAMETHASONE
          ELIXIR; ORAL
            DEXAMETHASONE
>A>   AA  +   ACTAVIS MID                0.5MG/5ML                               N84754 001                  Jul  CAHN
>D>   AA  +   ALPHARMA US                0.5MG/5ML                               N84754 001                  Jul  CAHN



        DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
          SYRUP; ORAL
            PROMETH W/ DEXTROMETHORPHAN
>A>   AA  +   ACTAVIS MID                15MG/5ML;6.25MG/5ML                     N88762 001  Oct 31, 1984    Jul  CAHN
>D>   AA  +   ALPHARMA US                15MG/5ML;6.25MG/5ML                     N88762 001  Oct 31, 1984    Jul  CAHN



        DIMETHYL SULFOXIDE
          SOLUTION; INTRAVESICAL
            RIMSO-50
>A>   AT  +   BIONICHE PHARMA            50%                                     N17788 001                  Jul  CAHN
>D>   AT  +   EDWARDS                    50%                                     N17788 001                  Jul  CAHN



        DIPYRIDAMOLE
          TABLET; ORAL
            DIPYRIDAMOLE
>D>         @ CLONMEL HLTHCARE           25MG                                    N88999 001  Feb 05, 1991    Jul  CAHN
>D>   AB                                 50MG                                    N89000 001  Feb 05, 1991    Jul  CAHN
>D>         @                            75MG                                    N89001 001  Feb 05, 1991    Jul  CAHN
>A>         @ GLENMARK PHARMA            25MG                                    N88999 001  Feb 05, 1991    Jul  CAHN
>A>   AB                                 50MG                                    N89000 001  Feb 05, 1991    Jul  CAHN
>A>         @                            75MG                                    N89001 001  Feb 05, 1991    Jul  CAHN



>A>     EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
>A>       TABLET; ORAL
>A>         ATRIPLA
>A>       +   GILEAD                     600MG;200MG;300MG                       N21937 001  Jul 12, 2006    Jul  NEWA



        EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
          INJECTABLE; INJECTION
            XYLOCAINE W/ EPINEPHRINE
>A>   AP  +   ABRAXIS BIOSCIENCE         0.005MG/ML;0.5%                         N06488 012                  Jul  CAHN
>A>   AP  +                              0.005MG/ML;1%                           N06488 018  Nov 13, 1986    Jul  CAHN
>A>   AP  +                              0.005MG/ML;1.5%                         N06488 017                  Jul  CAHN
>A>   AP  +                              0.005MG/ML;2%                           N06488 019  Nov 13, 1986    Jul  CAHN
>A>   AP  +                              0.01MG/ML;1%                            N06488 004                  Jul  CAHN
>A>         @                            0.01MG/ML;2%                            N06488 003                  Jul  CAHN
>A>         @                            0.02MG/ML;2%                            N06488 005                  Jul  CAHN
>D>   AP  +   ASTRAZENECA                0.005MG/ML;0.5%                         N06488 012                  Jul  CAHN
>D>   AP  +                              0.005MG/ML;1%                           N06488 018  Nov 13, 1986    Jul  CAHN
>D>   AP  +                              0.005MG/ML;1.5%                         N06488 017                  Jul  CAHN
>D>   AP  +                              0.005MG/ML;2%                           N06488 019  Nov 13, 1986    Jul  CAHN
>D>   AP  +                              0.01MG/ML;1%                            N06488 004                  Jul  CAHN
>D>         @                            0.01MG/ML;2%                            N06488 003                  Jul  CAHN
>D>         @                            0.02MG/ML;2%                            N06488 005                  Jul  CAHN



        ERYTHROMYCIN
          SWAB; TOPICAL
            ERYTHROMYCIN
>A>   AT      ALTANA                     2%                                      N65320 001  Jul 25, 2006    Jul  NEWA


        ESTRADIOL
          FILM, EXTENDED RELEASE; TRANSDERMAL
            CLIMARA
>D>   BX  +   BERLEX                     0.0375MG/24HR                           N20375 005  May 27, 2003    Jul  CFTG
>A>   AB  +                              0.0375MG/24HR                           N20375 005  May 27, 2003    Jul  CFTG
>D>       +                              0.06MG/24HR                             N20375 006  May 27, 2003    Jul  CFTG
>A>   AB  +                              0.06MG/24HR                             N20375 006  May 27, 2003    Jul  CFTG
            ESTRADIOL
>A>   AB      MYLAN                      0.0375MG/24HR                           N75182 004  Jul 20, 2006    Jul  NEWA
>A>   AB                                 0.06MG/24HR                             N75182 005  Jul 20, 2006    Jul  NEWA



        ETHACRYNATE SODIUM
          INJECTABLE; INJECTION
            EDECRIN
>A>       +   ATON                       EQ 50MG BASE/VIAL                       N16093 001                  Jul  CAHN
>D>       +   MERCK                      EQ 50MG BASE/VIAL                       N16093 001                  Jul  CAHN



>A>     ETONOGESTREL
>A>       IMPLANT; IMPLANTATION
>A>         IMPLANON
>A>       +   ORGANON USA INC            68MG/IMPLANT                            N21529 001  Jul 17, 2006    Jul  NEWA



        FENTANYL
          FILM, EXTENDED RELEASE; TRANSDERMAL
            FENTANYL
>A>   AB      LAVIPHARM LABS             25UGM/HR                                N77051 001  Aug 04, 2006    Jul  NEWA
>A>   AB                                 50UGM/HR                                N77051 002  Aug 04, 2006    Jul  NEWA
>A>   AB                                 75UGM/HR                                N77051 003  Aug 04, 2006    Jul  NEWA
>A>   AB                                 100UGM/HR                               N77051 004  Aug 04, 2006    Jul  NEWA



        FENTANYL CITRATE
          TROCHE/LOZENGE; ORAL
            FENTANYL
>D>         @ ANESTA                     EQ 0.1MG BASE                           N20195 007  Oct 30, 1995    Jul  CAHN
>D>         @                            EQ 0.2MG BASE                           N20195 001  Oct 04, 1993    Jul  CAHN
>D>         @                            EQ 0.3MG BASE                           N20195 002  Oct 04, 1993    Jul  CAHN
>D>         @                            EQ 0.4MG BASE                           N20195 003  Oct 04, 1993    Jul  CAHN
>A>         @ CEPHALON                   EQ 0.1MG BASE                           N20195 007  Oct 30, 1995    Jul  CAHN
>A>         @                            EQ 0.2MG BASE                           N20195 001  Oct 04, 1993    Jul  CAHN
>A>         @                            EQ 0.3MG BASE                           N20195 002  Oct 04, 1993    Jul  CAHN
>A>         @                            EQ 0.4MG BASE                           N20195 003  Oct 04, 1993    Jul  CAHN



        FINASTERIDE
          TABLET; ORAL
            FINASTERIDE
>A>   AB      DR REDDYS LABS INC         1MG                                     N76436 001  Jul 28, 2006    Jul  NEWA
            PROPECIA
>D>       +   MERCK                      1MG                                     N20788 001  Dec 19, 1997    Jul  CFTG
>A>   AB  +                              1MG                                     N20788 001  Dec 19, 1997    Jul  CFTG



        FLUNISOLIDE
          SPRAY, METERED; NASAL
            FLUNISOLIDE
>D>       +   BAUSCH AND LOMB            0.025MG/SPRAY                           N74805 001  Feb 20, 2002    Jul  CTEC
>A>   AB  +                              0.025MG/SPRAY                           N74805 001  Feb 20, 2002    Jul  CTEC
>A>   AB      QPHARMA                    0.025MG/SPRAY                           N77704 001  Aug 03, 2006    Jul  NEWA
       FLUOCINONIDE
          SOLUTION; TOPICAL
            FLUOCINONIDE
>A>   AT      ACTAVIS MID                0.05%                                   N71535 001  Dec 02, 1988    Jul  CAHN
>D>   AT      ALPHARMA US                0.05%                                   N71535 001  Dec 02, 1988    Jul  CAHN



        FLUOXETINE HYDROCHLORIDE
          SOLUTION; ORAL
            FLUOXETINE
>A>   AA      ACTAVIS MID                EQ 20MG BASE/5ML                        N75690 001  Jan 31, 2002    Jul  CAHN
>D>   AA      ALPHARMA US                EQ 20MG BASE/5ML                        N75690 001  Jan 31, 2002    Jul  CAHN



        FLUPHENAZINE HYDROCHLORIDE
          CONCENTRATE; ORAL
>D>         PROLIXIN
>D>   AA      APOTHECON                  5MG/ML                                  N70533 001  Nov 07, 1985    Jul  DISC
>A>         @                            5MG/ML                                  N70533 001  Nov 07, 1985    Jul  DISC



        FOLLITROPIN ALFA/BETA
          INJECTABLE; SUBCUTANEOUS
            FOLLISTIM AQ
>D>       +   ORGANON USA INC            150 IU/0.18ML                           N21211 003  Feb 11, 2004    Jul  DISC
>A>         @                            150 IU/0.18ML                           N21211 003  Feb 11, 2004    Jul  DISC
>D>         @                            300 IU/0.36ML                           N21211 001  Mar 23, 2004    Jul  CMFD
>A>       +                              300 IU/0.36ML                           N21211 001  Mar 23, 2004    Jul  CMFD



        GEMFIBROZIL
          TABLET; ORAL
            GEMFIBROZIL
>A>   AB      INVAGEN PHARMS             600MG                                   N77836 001  Jul 27, 2006    Jul  NEWA



>A>     GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
>A>       TABLET; ORAL
>A>         DUETACT
>A>           TAKEDA GLOBAL              2MG;30MG                                N21925 001  Jul 28, 2006    Jul  NEWA
>A>                                      4MG;30MG                                N21925 002  Jul 28, 2006    Jul  NEWA



        HALOPERIDOL LACTATE
          SOLUTION; ORAL
            HALOPERIDOL LACTATE
>A>           ACTAVIS MID                EQ 1MG BASE/ML                          N74536 001  Nov 02, 1995    Jul  CAHN
>D>           UDL                        EQ 1MG BASE/ML                          N74536 001  Nov 02, 1995    Jul  CAHN



        HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
          SYRUP; ORAL
            HYDROCODONE COMPOUND
>A>   AA      ACTAVIS MID                1.5MG/5ML;5MG/5ML                       N88017 001  Jul 05, 1983    Jul  CAHN
>D>   AA      ALPHARMA US                1.5MG/5ML;5MG/5ML                       N88017 001  Jul 05, 1983    Jul  CAHN



        HYDROXYZINE HYDROCHLORIDE
          SYRUP; ORAL
            HYDROXYZINE HYDROCHLORIDE
>A>   AA  +   ACTAVIS MID                10MG/5ML                                N86880 001                  Jul  CAHN
>D>   AA  +   ALPHARMA US                10MG/5ML                                N86880 001                  Jul  CAHN



        IBUPROFEN
          SUSPENSION; ORAL
            IBUPROFEN
>A>   AB      ACTAVIS MID                100MG/5ML                               N74978 001  Mar 25, 1998    Jul  CAHN
>D>   AB      ALPHARMA US                100MG/5ML                               N74978 001  Mar 25, 1998    Jul  CAHN



        IPRATROPIUM BROMIDE
          SOLUTION; INHALATION
            IPRATROPIUM BROMIDE
>A>   AN      ACTAVIS MID                0.02%                                   N75111 001  Apr 22, 1999    Jul  CAHN
>D>   AN      ALPHARMA US                0.02%                                   N75111 001  Apr 22, 1999    Jul  CAHN



        KETOCONAZOLE
>A>       GEL; TOPICAL
>A>         XOLEGEL
>A>       +   BARRIER THERAP             2%                                      N21946 001  Jul 28, 2006    Jul  NEWA



        KETOPROFEN
          CAPSULE; ORAL
            KETOPROFEN
>D>   AB      CLONMEL HLTHCARE           25MG                                    N74014 001  Jan 29, 1993    Jul  CAHN
>D>   AB                                 50MG                                    N74014 002  Jan 29, 1993    Jul  CAHN
>D>   AB                                 75MG                                    N74014 003  Jan 29, 1993    Jul  CAHN
>A>   AB      RADIUS PHARMS              25MG                                    N74014 001  Jan 29, 1993    Jul  CAHN
>A>   AB                                 50MG                                    N74014 002  Jan 29, 1993    Jul  CAHN
>A>   AB                                 75MG                                    N74014 003  Jan 29, 1993    Jul  CAHN



        LACTULOSE
          SOLUTION; ORAL
            CONSTULOSE
>A>   AA  +   ACTAVIS MID                10GM/15ML                               N70288 001  Aug 15, 1988    Jul  CAHN
>D>   AA  +   ALPHARMA US                10GM/15ML                               N70288 001  Aug 15, 1988    Jul  CAHN
          SOLUTION; ORAL, RECTAL
            ENULOSE
>A>   AA  +   ACTAVIS MID                10GM/15ML                               N71548 001  Aug 15, 1988    Jul  CAHN
>D>   AA  +   ALPHARMA US                10GM/15ML                               N71548 001  Aug 15, 1988    Jul  CAHN



        LENALIDOMIDE
          CAPSULE; ORAL
            REVLIMID
>D>       +   CELGENE                    10MG                                    N21880 002  Dec 27, 2005    Jul  CRLD
>A>                                      10MG                                    N21880 002  Dec 27, 2005    Jul  CRLD
>A>                                      15MG                                    N21880 003  Jun 29, 2006    Jul  NEWA
>A>       +                              25MG                                    N21880 004  Jun 29, 2006    Jul  NEWA



        LEVETIRACETAM
>A>       INJECTABLE; IV (INFUSION)
>A>         KEPPRA
>A>       +   UCB INC                    500MG/5ML (100MG/ML)                    N21872 001  Jul 31, 2006    Jul  NEWA



        LIDOCAINE HYDROCHLORIDE
          INJECTABLE; INJECTION
            XYLOCAINE
>A>   AP  +   ABRAXIS BIOSCIENCE         0.5%                                    N06488 008                  Jul  CAHN
>A>   AP  +                              1%                                      N06488 007                  Jul  CAHN
>A>   AP  +                              1.5%                                    N06488 010                  Jul  CAHN
>A>         @                            2%                                      N06488 002                  Jul  CAHN
>D>   AP  +   ASTRAZENECA                0.5%                                    N06488 008                  Jul  CAHN
>D>   AP  +                              1%                                      N06488 007                  Jul  CAHN
>D>   AP  +                              1.5%                                    N06488 010                  Jul  CAHN
>D>         @                            2%                                      N06488 002                  Jul  CAHN
            XYLOCAINE 4% PRESERVATIVE FREE
>A>   AP  +   ABRAXIS BIOSCIENCE         4%                                      N10417 001                  Jul  CAHN
>D>   AP  +   ASTRAZENECA                4%                                      N10417 001                  Jul  CAHN
            XYLOCAINE PRESERVATIVE FREE
>A>   AP      ABRAXIS BIOSCIENCE         1%                                      N16801 005  Jan 19, 1988    Jul  CAHN
>A>   AP  +                              2%                                      N16801 001                  Jul  CAHN
>A>   AP                                 4%                                      N16801 002                  Jul  CAHN
>A>   AP  +                              10%                                     N16801 003                  Jul  CAHN
>A>   AP  +                              20%                                     N16801 004                  Jul  CAHN
>D>   AP      ASTRAZENECA                1%                                      N16801 005  Jan 19, 1988    Jul  CAHN
>D>   AP  +                              2%                                      N16801 001                  Jul  CAHN
>D>   AP                                 4%                                      N16801 002                  Jul  CAHN
>D>   AP  +                              10%                                     N16801 003                  Jul  CAHN
>D>   AP  +                              20%                                     N16801 004                  Jul  CAHN
          INJECTABLE; SPINAL
            XYLOCAINE 1.5% W/ DEXTROSE 7.5%
>A>         @ ABRAXIS BIOSCIENCE         1.5%                                    N16297 001                  Jul  CAHN
>D>         @ ASTRAZENECA                1.5%                                    N16297 001                  Jul  CAHN
          JELLY; TOPICAL
            XYLOCAINE
>A>   AT  +   ABRAXIS BIOSCIENCE         2%                                      N08816 001                  Jul  CAHN
>D>   AT  +   ASTRAZENECA                2%                                      N08816 001                  Jul  CAHN
          SOLUTION; ORAL
            LIDOCAINE HYDROCHLORIDE VISCOUS
>A>   AT      ACTAVIS MID                2%                                      N86578 001                  Jul  CAHN
>D>   AT      ALPHARMA US                2%                                      N86578 001                  Jul  CAHN
            XYLOCAINE VISCOUS
>A>   AT  +   ABRAXIS BIOSCIENCE         2%                                      N09470 001                  Jul  CAHN
>D>   AT  +   ASTRAZENECA                2%                                      N09470 001                  Jul  CAHN
          SOLUTION; TOPICAL
            XYLOCAINE 4% PRESERVATIVE FREE
>A>   AT  +   ABRAXIS BIOSCIENCE         4%                                      N10417 002                  Jul  CAHN
>D>   AT  +   ASTRAZENECA                4%                                      N10417 002                  Jul  CAHN



        LIDOCAINE; PRILOCAINE
          CREAM; TOPICAL
            EMLA
>A>   AB  +   ABRAXIS BIOSCIENCE         2.5%;2.5%                               N19941 001  Dec 30, 1992    Jul  CAHN
>D>   AB  +   ASTRAZENECA                2.5%;2.5%                               N19941 001  Dec 30, 1992    Jul  CAHN



        LINDANE
          LOTION; TOPICAL
            LINDANE
>A>   AT  +   ACTAVIS MID                1%                                      N87313 001                  Jul  CAHN
>D>   AT  +   ALPHARMA US                1%                                      N87313 001                  Jul  CAHN
          SHAMPOO; TOPICAL
            LINDANE
>A>   AT  +   ACTAVIS MID                1%                                      N87266 001                  Jul  CAHN
>D>   AT  +   ALPHARMA US                1%                                      N87266 001                  Jul  CAHN



        LITHIUM CARBONATE
          TABLET, EXTENDED RELEASE; ORAL
>D>         ESKALITH CR
>D>   AB  +   GLAXOSMITHKLINE            450MG                                   N18152 001  Mar 29, 1982    Jul  DISC
>A>         @                            450MG                                   N18152 001  Mar 29, 1982    Jul  DISC
            LITHIUM CARBONATE
>D>   AB      BARR                       450MG                                   N76366 001  Aug 21, 2003    Jul  DISC
>A>         @                            450MG                                   N76366 001  Aug 21, 2003    Jul  DISC
>D>   AB      ROXANE                     450MG                                   N76691 001  Jan 05, 2004    Jul  CRLD
>A>   AB  +                              450MG                                   N76691 001  Jan 05, 2004    Jul  CRLD



        LOVASTATIN; NIACIN
          TABLET, EXTENDED RELEASE; ORAL
            ADVICOR
>A>       +   KOS LIFE                   40MG;1GM                                N21249 004  Apr 27, 2006    Jul  NEWA



>A>     MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
>A>       SOLUTION; INJECTION
>A>         NORMOCARB HF 25
>A>       +   DIALYSIS SUPS              0.21GM/100ML;2.8GM/100ML;9.07GM/100     N21910 001  Jul 26, 2006    Jul  NEWA
>A>         NORMOCARB HF 35
>A>       +   DIALYSIS SUPS              0.21GM/100ML;3.97GM/100ML;8.3GM/100     N21910 002  Jul 26, 2006    Jul  NEWA



        MELOXICAM
          TABLET; ORAL
>A>         MELOXICAM
>A>   AB      ACTAVIS TOTOWA             7.5MG                                   N77938 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77938 002  Jul 19, 2006    Jul  NEWA
>A>   AB      APOTEX INC                 7.5MG                                   N77882 001  Jul 20, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77882 002  Jul 20, 2006    Jul  NEWA
>A>   AB      BRECKENRIDGE PHARM         7.5MG                                   N77920 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77920 002  Jul 19, 2006    Jul  NEWA
>A>   AB      CARACO                     7.5MG                                   N77937 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77937 002  Jul 19, 2006    Jul  NEWA
>A>   AB      COREPHARMA                 7.5MG                                   N77930 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77930 002  Jul 19, 2006    Jul  NEWA
>A>   AB      DR REDDYS LABS INC         7.5MG                                   N77931 001  Jul 25, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77931 002  Jul 25, 2006    Jul  NEWA
>A>   AB      GENPHARM                   7.5MG                                   N77934 001  Jul 20, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77934 002  Jul 20, 2006    Jul  NEWA
>A>   AB      GLENMARK PHARMS            7.5MG                                   N77932 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77932 002  Jul 19, 2006    Jul  NEWA
>A>   AB      LUPIN PHARMS               7.5MG                                   N77944 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77944 002  Jul 19, 2006    Jul  NEWA
>A>   AB      MUTUAL PHARM               7.5MG                                   N77935 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77935 002  Jul 19, 2006    Jul  NEWA
>A>   AB      MYLAN                      7.5MG                                   N77923 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77923 002  Jul 19, 2006    Jul  NEWA
>A>   AB      PAR PHARM                  7.5MG                                   N77933 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77933 002  Jul 19, 2006    Jul  NEWA
>A>   AB      ROXANE                     7.5MG                                   N77925 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77925 002  Jul 19, 2006    Jul  NEWA
>A>   AB      TEVA PHARMS                7.5MG                                   N77936 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77936 002  Jul 19, 2006    Jul  NEWA
>A>   AB      WATSON LABS                7.5MG                                   N77929 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77929 002  Jul 19, 2006    Jul  NEWA
>A>   AB      ZYDUS PHARMS USA           7.5MG                                   N77921 001  Jul 19, 2006    Jul  NEWA
>A>   AB                                 15MG                                    N77921 002  Jul 19, 2006    Jul  NEWA
            MOBIC
>D>           BOEHRINGER                 7.5MG                                   N20938 001  Apr 13, 2000    Jul  CFTG
>A>   AB                                 7.5MG                                   N20938 001  Apr 13, 2000    Jul  CFTG
>D>       +                              15MG                                    N20938 002  Aug 23, 2000    Jul  CFTG
>A>   AB  +                              15MG                                    N20938 002  Aug 23, 2000    Jul  CFTG



        MESALAMINE
          SUPPOSITORY; RECTAL
            ROWASA
>A>         @ ALAVEN PHARM               500MG                                   N19919 001  Dec 18, 1990    Jul  CAHN
>D>         @ SOLVAY                     500MG                                   N19919 001  Dec 18, 1990    Jul  CAHN



        METFORMIN HYDROCHLORIDE
          TABLET, EXTENDED RELEASE; ORAL
            METFORMIN HYDROCHLORIDE
>A>   AB      NOSTRUM                    500MG                                   N76756 001  Jul 26, 2006    Jul  NEWA
          TABLET; ORAL
            METFORMIN HYDROCHLORIDE
>A>   AB      AMNEAL PHARM               500MG                                   N77853 001  Jul 28, 2006    Jul  NEWA
>A>   AB                                 850MG                                   N77853 002  Jul 28, 2006    Jul  NEWA
>A>   AB                                 1GM                                     N77853 003  Jul 28, 2006    Jul  NEWA



        METHOTREXATE SODIUM
          INJECTABLE; INJECTION
            METHOTREXATE
>D>   AP      ABRAXIS PHARM              EQ 250MG BASE/10ML (25MG/ML)            N40263 002  Feb 26, 1999    Jul  CRLD
>A>   AP  +                              EQ 250MG BASE/10ML (25MG/ML)            N40263 002  Feb 26, 1999    Jul  CRLD



        METOCLOPRAMIDE HYDROCHLORIDE
          SOLUTION; ORAL
            METOCLOPRAMIDE HYDROCHLORIDE
>A>   AA      ACTAVIS MID                EQ 5MG BASE/5ML                         N71340 001  Aug 18, 1988    Jul  CAHN
>D>   AA      ALPHARMA US                EQ 5MG BASE/5ML                         N71340 001  Aug 18, 1988    Jul  CAHN



        METOPROLOL SUCCINATE
          TABLET, EXTENDED RELEASE; ORAL
>A>         METOPROLOL SUCCINATE
>A>   AB      SANDOZ                     EQ 25MG TARTRATE                        N76969 001  Jul 31, 2006    Jul  NEWA
            TOPROL-XL
>D>           ASTRAZENECA                EQ 25MG TARTRATE                        N19962 004  Feb 05, 2001    Jul  CFTG
>A>   AB                                 EQ 25MG TARTRATE                        N19962 004  Feb 05, 2001    Jul  CFTG



        METRONIDAZOLE
          GEL; TOPICAL
            METRONIDAZOLE
>A>   AB      TARO                       0.75%                                   N77819 001  Jul 18, 2006    Jul  NEWA



        NABUMETONE
          TABLET; ORAL
            NABUMETONE
>D>   AB      TEVA                       750MG                                   N75189 002  Sep 24, 2001    Jul  CRLD
>A>   AB  +                              750MG                                   N75189 002  Sep 24, 2001    Jul  CRLD
>D>         RELAFEN
>D>   AB      SMITHKLINE BEECHAM         500MG                                   N19583 001  Dec 24, 1991    Jul  DISC
>A>         @                            500MG                                   N19583 001  Dec 24, 1991    Jul  DISC
>D>   AB  +                              750MG                                   N19583 002  Dec 24, 1991    Jul  DISC
>A>         @                            750MG                                   N19583 002  Dec 24, 1991    Jul  DISC



        NEOMYCIN SULFATE
          TABLET; ORAL
            NEOMYCIN SULFATE
>D>         @ BRISTOL MYERS              EQ 350MG BASE                           N60365 001                  Jul  CPOT
>A>         @                            500MG                                   N60365 001                  Jul  CPOT
>D>         @ LANNETT                    EQ 350MG BASE                           N60607 001                  Jul  CPOT
>A>         @                            500MG                                   N60607 001                  Jul  CPOT
>D>         @ LILLY                      EQ 350MG BASE                           N60385 001                  Jul  CPOT
>A>         @                            500MG                                   N60385 001                  Jul  CPOT
>D>         @ ROXANE                     EQ 350MG BASE                           N62173 001                  Jul  CPOT
>A>         @                            500MG                                   N62173 001                  Jul  CPOT
>D>         @ SANDOZ                     EQ 350MG BASE                           N61586 001                  Jul  CPOT
>A>         @                            500MG                                   N61586 001                  Jul  CPOT
>D>       +   TEVA                       EQ 350MG BASE                           N60304 001                  Jul  CFTG
>A>   AB  +                              500MG                                   N60304 001                  Jul  CFTG
>A>   AB      X GEN PHARMS               500MG                                   N65220 001  Jul 28, 2006    Jul  NEWA



        NEOMYCIN SULFATE; POLYMYXIN B SULFATE
          SOLUTION; IRRIGATION
            NEOMYCIN AND POLYMYXIN B SULFATE
>A>   AT      WATSON LABS                EQ 40MG BASE/ML;200,000 UNITS/ML        N62664 001  Apr 08, 1986    Jul  CMFD
            NEOMYCIN AND POLYMYXIN B SULFATES
>D>         @ WATSON LABS                EQ 40MG BASE/ML;200,000 UNITS/ML        N62664 001  Apr 08, 1986    Jul  CMFD



        NYSTATIN
          SUSPENSION; ORAL
            NYSTATIN
>A>   AA      ACTAVIS MID                100,000 UNITS/ML                        N62349 001  Jul 14, 1982    Jul  CAHN
>D>   AA      ALPHARMA US                100,000 UNITS/ML                        N62349 001  Jul 14, 1982    Jul  CAHN



        PENTOXIFYLLINE
          TABLET, EXTENDED RELEASE; ORAL
            PENTOXIFYLLINE
>D>   AB      CLONMEL HLTHCARE           400MG                                   N74877 001  Jul 08, 1997    Jul  CAHN
>A>   AB      RADIUS PHARMS              400MG                                   N74877 001  Jul 08, 1997    Jul  CAHN
       PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
          SYRUP; ORAL
            PROMETH VC PLAIN
>A>       +   ACTAVIS MID                5MG/5ML;6.25MG/5ML                      N88761 001  Nov 08, 1984    Jul  CAHN
>D>       +   ALPHARMA US                5MG/5ML;6.25MG/5ML                      N88761 001  Nov 08, 1984    Jul  CAHN



        PHENYTOIN
          SUSPENSION; ORAL
            PHENYTOIN
>A>   AB      ACTAVIS MID                125MG/5ML                               N89892 001  Sep 25, 1992    Jul  CAHN
>D>   AB      ALPHARMA US                125MG/5ML                               N89892 001  Sep 25, 1992    Jul  CAHN



        PRIMIDONE
          TABLET; ORAL
            PRIMIDONE
>A>   AB      WEST WARD                  50MG                                    N40667 001  Jul 27, 2006    Jul  NEWA
>A>   AB                                 250MG                                   N40667 002  Jul 27, 2006    Jul  NEWA



        PROMETHAZINE HYDROCHLORIDE
          SYRUP; ORAL
            PROMETH PLAIN
>A>         @ ACTAVIS MID                6.25MG/5ML                              N85953 001                  Jul  CAHN
>D>         @ ALPHARMA US                6.25MG/5ML                              N85953 001                  Jul  CAHN
          TABLET; ORAL
            PROMETHAZINE HYDROCHLORIDE
>A>   AB      KVK-TECH INC               25MG                                    N40712 001  Jul 31, 2006    Jul  NEWA
>A>   AB                                 50MG                                    N40713 001  Jul 31, 2006    Jul  NEWA
>A>   AB      VINTAGE PHARMS             12.5MG                                  N40622 001  Jul 18, 2006    Jul  NEWA
>A>   AB                                 25MG                                    N40622 002  Jul 18, 2006    Jul  NEWA
>A>   AB                                 50MG                                    N40622 003  Jul 18, 2006    Jul  NEWA
>D>           ZYDUS PHARMS USA           12.5MG                                  N40596 001  Nov 18, 2005    Jul  CTEC
>A>   AB                                 12.5MG                                  N40596 001  Nov 18, 2005    Jul  CTEC



        PROPOFOL
          INJECTABLE; INJECTION
            DIPRIVAN
>A>         @ ABRAXIS BIOSCIENCE         10MG/ML                                 N19627 001  Oct 02, 1989    Jul  CAHN
>A>   AB  +                              10MG/ML                                 N19627 002  Jun 11, 1996    Jul  CAHN
>D>         @ ASTRAZENECA                10MG/ML                                 N19627 001  Oct 02, 1989    Jul  CAHN
>D>   AB  +                              10MG/ML                                 N19627 002  Jun 11, 1996    Jul  CAHN



        QUINIDINE SULFATE
          TABLET; ORAL
            QUINIDINE SULFATE
>D>         @ MUTUAL PHARM               300MG                                   N81031 001  Apr 14, 1989    Jul  CMFD
>A>   AB                                 300MG                                   N81031 001  Apr 14, 1989    Jul  CMFD
>D>         @ WATSON LABS                200MG                                   N83288 001                  Jul  CMFD
>A>   AB                                 200MG                                   N83288 001                  Jul  CMFD



        ROPIVACAINE HYDROCHLORIDE MONOHYDRATE
          INJECTABLE; INJECTION
            NAROPIN
>A>           ABRAXIS BIOSCIENCE         2MG/ML                                  N20533 001  Sep 24, 1996    Jul  CAHN
>A>                                      5MG/ML                                  N20533 003  Sep 24, 1996    Jul  CAHN
>A>                                      7.5MG/ML                                N20533 004  Sep 24, 1996    Jul  CAHN
>A>       +                              10MG/ML                                 N20533 005  Sep 24, 1996    Jul  CAHN
>D>           ASTRAZENECA                2MG/ML                                  N20533 001  Sep 24, 1996    Jul  CAHN
>D>                                      5MG/ML                                  N20533 003  Sep 24, 1996    Jul  CAHN
>D>                                      7.5MG/ML                                N20533 004  Sep 24, 1996    Jul  CAHN
>D>       +                              10MG/ML                                 N20533 005  Sep 24, 1996    Jul  CAHN



        SELENIUM SULFIDE
          LOTION/SHAMPOO; TOPICAL
            SELENIUM SULFIDE
>A>   AT      ACTAVIS MID                2.5%                                    N84394 001                  Jul  CAHN
>D>   AT      ALPHARMA US                2.5%                                    N84394 001                  Jul  CAHN



        SODIUM CHLORIDE
>A>       INJECTABLE; INTRAVASCULAR
>A>         SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>A>       +   MALLINCKRODT               45MG/50ML (0.9MG/ML)                    N21569 001  Jul 27, 2006    Jul  NEWA
>A>                                      112.5MG/125ML (0.9MG/ML)                N21569 002  Jul 27, 2006    Jul  NEWA



        SOMATROPIN RECOMBINANT
          INJECTABLE; INJECTION
>D>         NUTROPIN DEPOT
>D>       +   GENENTECH                  13.5MG/VIAL                             N21075 001  Dec 22, 1999    Jul  DISC
>A>         @                            13.5MG/VIAL                             N21075 001  Dec 22, 1999    Jul  DISC
>D>       +                              18MG/VIAL                               N21075 002  Dec 22, 1999    Jul  DISC
>A>         @                            18MG/VIAL                               N21075 002  Dec 22, 1999    Jul  DISC
>D>       +                              22.5MG/VIAL                             N21075 003  Dec 22, 1999    Jul  DISC
>A>         @                            22.5MG/VIAL                             N21075 003  Dec 22, 1999    Jul  DISC



        SULFAMETHOXAZOLE; TRIMETHOPRIM
          SUSPENSION; ORAL
            SULFATRIM
>A>   AB      ACTAVIS MID                200MG/5ML;40MG/5ML                      N18615 002  Jan 07, 1983    Jul  CAHN
>D>   AB      ALPHARMA US                200MG/5ML;40MG/5ML                      N18615 002  Jan 07, 1983    Jul  CAHN
            SULFATRIM PEDIATRIC
>A>   AB      ACTAVIS MID                200MG/5ML;40MG/5ML                      N18615 001  Jan 07, 1983    Jul  CAHN
>D>   AB      ALPHARMA US                200MG/5ML;40MG/5ML                      N18615 001  Jan 07, 1983    Jul  CAHN



        SULINDAC
          TABLET; ORAL
            SULINDAC
>D>         @ CLONMEL HLTHCARE           150MG                                   N73261 001  Sep 06, 1991    Jul  CAHN
>D>         @                            200MG                                   N73262 001  Sep 06, 1991    Jul  CAHN
>A>         @ RADIUS PHARMS              150MG                                   N73261 001  Sep 06, 1991    Jul  CAHN
>A>         @                            200MG                                   N73262 001  Sep 06, 1991    Jul  CAHN



        SUNITINIB MALATE
          CAPSULE; ORAL
            SUTENT
>A>           CPPI CV                    EQ 12.5MG BASE                          N21938 001  Jan 26, 2006    Jul  CAHN
>A>                                      EQ 25MG BASE                            N21938 002  Jan 26, 2006    Jul  CAHN
>A>       +                              EQ 50MG BASE                            N21938 003  Jan 26, 2006    Jul  CAHN
>D>           PFIZER                     EQ 12.5MG BASE                          N21938 001  Jan 26, 2006    Jul  CAHN
>D>                                      EQ 25MG BASE                            N21938 002  Jan 26, 2006    Jul  CAHN
>D>       +                              EQ 50MG BASE                            N21938 003  Jan 26, 2006    Jul  CAHN



        TAMOXIFEN CITRATE
          SOLUTION; ORAL
            SOLTAMOX
>D>       +   SAVIENT PHARMA             EQ 10MG BASE/5ML                        N21807 001  Oct 29, 2005    Jul  CAHN
>A>       +   SAVIENT PHARMS             EQ 10MG BASE/5ML                        N21807 001  Oct 29, 2005    Jul  CAHN



        TERCONAZOLE
          CREAM; VAGINAL
>D>         TERAZOL 3
>D>   AB  +   ORTHO MCNEIL               0.8%                                    N19964 001  Feb 21, 1991    Jul  DISC
>A>         @                            0.8%                                    N19964 001  Feb 21, 1991    Jul  DISC
>D>         TERAZOL 7
>D>   AB  +   ORTHO MCNEIL               0.4%                                    N19579 001  Dec 31, 1987    Jul  DISC
>A>         @                            0.4%                                    N19579 001  Dec 31, 1987    Jul  DISC
            TERCONAZOLE
>D>   AB      TARO                       0.4%                                    N76043 001  Jan 19, 2005    Jul  CRLD
>A>   AB  +                              0.4%                                    N76043 001  Jan 19, 2005    Jul  CRLD
>D>   AB                                 0.8%                                    N75953 001  Apr 06, 2004    Jul  CRLD
>A>   BX  +                              0.8%                                    N75953 001  Apr 06, 2004    Jul  CRLD



        THEOPHYLLINE
          ELIXIR; ORAL
            THEOPHYLLINE
>A>   AA      ACTAVIS MID                80MG/15ML                               N85863 001                  Jul  CAHN
>D>   AA      ALPHARMA US                80MG/15ML                               N85863 001                  Jul  CAHN



        THIORIDAZINE HYDROCHLORIDE
          CONCENTRATE; ORAL
            THIORIDAZINE HYDROCHLORIDE
>A>   AA      ACTAVIS MID                100MG/ML                                N88229 001  Aug 23, 1983    Jul  CAHN
>D>   AA      ALPHARMA US                100MG/ML                                N88229 001  Aug 23, 1983    Jul  CAHN


        TOBRAMYCIN
          SOLUTION; INHALATION
            TOBI
>D>       +   CHIRON                     300MG/5ML                               N50753 001  Dec 22, 1997    Jul  CAHN
>A>       +   NOVARTIS PHARMS            300MG/5ML                               N50753 001  Dec 22, 1997    Jul  CAHN



        TOBRAMYCIN SULFATE
          INJECTABLE; INJECTION
            TOBRAMYCIN
>D>   AP      ABRAXIS PHARM              EQ 40MG BASE/ML                         N65122 002  Nov 29, 2002    Jul  CRLD
>A>   AP  +                              EQ 40MG BASE/ML                         N65122 002  Nov 29, 2002    Jul  CRLD



        TRIMIPRAMINE MALEATE
          CAPSULE; ORAL
            SURMONTIL
>D>           ODYSSEY PHARMS             EQ 25MG BASE                            N16792 001                  Jul  CFTG
>A>   AB                                 EQ 25MG BASE                            N16792 001                  Jul  CFTG
>D>                                      EQ 50MG BASE                            N16792 002                  Jul  CFTG
>A>   AB                                 EQ 50MG BASE                            N16792 002                  Jul  CFTG
>D>       +                              EQ 100MG BASE                           N16792 003  Sep 15, 1982    Jul  CFTG
>A>   AB  +                              EQ 100MG BASE                           N16792 003  Sep 15, 1982    Jul  CFTG
>A>         TRIMIPRAMINE MALEATE
>A>   AB      ACTAVIS TOTOWA             EQ 25MG BASE                            N77361 001  Aug 02, 2006    Jul  NEWA
>A>   AB                                 EQ 50MG BASE                            N77361 002  Aug 02, 2006    Jul  NEWA
>A>   AB                                 EQ 100MG BASE                           N77361 003  Aug 02, 2006    Jul  NEWA



        URSODIOL
          CAPSULE; ORAL
            URSODIOL
>A>   AB      COREPHARMA                 300MG                                   N77895 001  Jul 27, 2006    Jul  NEWA



        VALRUBICIN
          SOLUTION; INTRAVESICAL
            VALSTAR PRESERVATIVE FREE
>D>       +   ANTHRA                     40MG/ML                                 N20892 001  Sep 25, 1998    Jul  CAHN
>A>       +   VALERA                     40MG/ML                                 N20892 001  Sep 25, 1998    Jul  CAHN



        VARENICLINE TARTRATE
          TABLET; ORAL
            CHANTIX
>A>           CPPI CV                    EQ 0.5MG BASE                           N21928 001  May 10, 2006    Jul  CAHN
>A>       +                              EQ 1MG BASE                             N21928 002  May 10, 2006    Jul  CAHN
>D>           PFIZER                     EQ 0.5MG BASE                           N21928 001  May 10, 2006    Jul  CAHN
>D>       +                              EQ 1MG BASE                             N21928 002  May 10, 2006    Jul  CAHN



        VENLAFAXINE HYDROCHLORIDE
          TABLET; ORAL
            EFFEXOR
>D>           WYETH PHARMS INC           EQ 25MG BASE                            N20151 002  Dec 28, 1993    Jul  CFTG
>A>   AB                                 EQ 25MG BASE                            N20151 002  Dec 28, 1993    Jul  CFTG
>D>                                      EQ 37.5MG BASE                          N20151 006  Dec 28, 1993    Jul  CFTG
>A>   AB                                 EQ 37.5MG BASE                          N20151 006  Dec 28, 1993    Jul  CFTG
>D>       +                              EQ 50MG BASE                            N20151 003  Dec 28, 1993    Jul  CFTG
>A>   AB  +                              EQ 50MG BASE                            N20151 003  Dec 28, 1993    Jul  CFTG
>D>                                      EQ 75MG BASE                            N20151 004  Dec 28, 1993    Jul  CFTG
>A>   AB                                 EQ 75MG BASE                            N20151 004  Dec 28, 1993    Jul  CFTG
>D>                                      EQ 100MG BASE                           N20151 005  Dec 28, 1993    Jul  CFTG
>A>   AB                                 EQ 100MG BASE                           N20151 005  Dec 28, 1993    Jul  CFTG
>A>         VENLAFAXINE HYDROCHLORIDE
>A>   AB      TEVA                       EQ 25MG BASE                            N76690 001  Aug 03, 2006    Jul  CTNA
>A>   AB                                 EQ 37.5MG BASE                          N76690 002  Aug 03, 2006    Jul  NEWA
>A>   AB                                 EQ 50MG BASE                            N76690 003  Aug 03, 2006    Jul  NEWA
>A>   AB                                 EQ 75MG BASE                            N76690 004  Aug 03, 2006    Jul  CTNA
>A>   AB                                 EQ 100MG BASE                           N76690 005  Aug 03, 2006    Jul  NEWA


        VERAPAMIL HYDROCHLORIDE
          TABLET; ORAL
            VERAPAMIL HYDROCHLORIDE
>D>         @ CLONMEL HLTHCARE           80MG                                    N71880 001  Apr 05, 1988    Jul  CAHN
>D>         @                            120MG                                   N71881 001  Apr 05, 1988    Jul  CAHN
>A>         @ RADIUS PHARMS              80MG                                    N71880 001  Apr 05, 1988    Jul  CAHN
>A>         @                            120MG                                   N71881 001  Apr 05, 1988    Jul  CAHN



        ZONISAMIDE
          CAPSULE; ORAL
            ZONISAMIDE
>A>   AB      WOCKHARDT                  25MG                                    N77636 003  Jul 27, 2006    Jul  NEWA
>A>   AB                                 50MG                                    N77636 002  Jul 27, 2006    Jul  NEWA

ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

 



>A>     AVOBENZONE; ECAMSULE; OCTOCRYLENE
>A>       CREAM; TOPICAL
>A>         ANTHELIOS SX
>A>       +   LOREAL USA                 2%;2%;10%                               N21502 001  Jul 21, 2006    Jul  NEWA



        CROMOLYN SODIUM
          SPRAY, METERED; NASAL
            CROMOLYN SODIUM
>A>           ACTAVIS MID                5.2MG/SPRAY                             N74800 001  Jul 26, 2001    Jul  CAHN
>D>           ALPHARMA US                5.2MG/SPRAY                             N74800 001  Jul 26, 2001    Jul  CAHN



        IBUPROFEN
          SUSPENSION; ORAL
            CHILDREN'S ELIXSURE
>A>           ALTERNA-TCHP LLC           100MG/5ML                               N21604 001  Jan 07, 2004    Jul  CAHN
>D>           TARO                       100MG/5ML                               N21604 001  Jan 07, 2004    Jul  CAHN
            IBUPROFEN
>A>           ACTAVIS MID                100MG/5ML                               N74916 001  Apr 30, 1999    Jul  CAHN
>D>           ALPHARMA US                100MG/5ML                               N74916 001  Apr 30, 1999    Jul  CAHN



        MINOXIDIL
          SOLUTION; TOPICAL
            MINOXIDIL (FOR MEN)
>A>           ACTAVIS MID                2%                                      N74588 001  Apr 05, 1996    Jul  CAHN
>D>           ALPHARMA US                2%                                      N74588 001  Apr 05, 1996    Jul  CAHN
            MINOXIDIL EXTRA STRENGTH (FOR MEN)
>A>           ACTAVIS MID                5%                                      N75518 001  Nov 17, 2000    Jul  CAHN
>D>           ALPHARMA US                5%                                      N75518 001  Nov 17, 2000    Jul  CAHN



        NAPROXEN SODIUM
>D>       CAPSULE; ORAL
>D>         NAPROXEN SODIUM
>D>       +   BANNER PHARMACAPS          EQ 200MG BASE                           N21920 001  Feb 17, 2006    Jul  DISC
>A>         @                            EQ 200MG BASE                           N21920 001  Feb 17, 2006    Jul  DISC



        TERBINAFINE
>A>       GEL; TOPICAL
>A>         LAMISIL AT
>A>       +   NOVARTIS                   1%                                      N21958 001  Jul 24, 2006    Jul  NEWA

 

 
-